1993 - Sarah Cannon began as the Sarah Cannon Cancer Center at Centennial Medical Center.
1995 - Minnie Pearl Research Center
1997 - Phase 1 Clinical Trials Program launches, the first drug development program outside of an academic setting.
2004 - Formally named Sarah Cannon Research Institute
2007 - Sarah Cannon launches Cardiovascular research focus
2009 - Sarah Cannon Research Institute — UK begins; establishing the first clinical trials program in the UK outside the NHS and the first private molecular profiling laboratory.
2010 - Sarah Cannon established as HCA's global cancer institute. Sarah Cannon core market established in London.
2011 - Sarah Cannon core markets expanded to Nashville, Denver and San Antonio. Sarah Cannon Blood Cancer Network launched.
2012 - Key physician leadership joins Sarah Cannon. Sarah Cannon core markets expanded to Austin, Oklahoma University, and Dallas.
2013 - Sarah Cannon core markets expanded to Kansas City.
2015 - Sarah Cannon markets expanded to Richmond and Gainesville. Sarah Cannon launches orthopedic support in Nashville.
2017 - Sarah Cannon announces merger with Genospace.